Skip to content

ORBIMED ADVISORS LLC: MBX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on MBX, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 3,074,853 MBX shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 3,074,853 shares
    Change vs previous 13F -353,883 shares

    3.31% of the 13F portfolio, value $180,247,883.

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

  2. period ended2026-06-30
    13F 3,428,736 shares
    Change vs previous 13F -209,151 shares

    3.58% of the 13F portfolio, value $189,266,227.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 3,637,887 shares
    Change vs previous 13F -297,316 shares

    2.37% of the 13F portfolio, value $108,590,927.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 3,935,203 shares
    Change vs previous 13F -67,684 shares

    2.54% of the 13F portfolio, value $124,116,303.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 4,002,887 shares
    Change vs previous 13F 0 shares

    1.68% of the 13F portfolio, value $70,050,523.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-06-30
    13F 4,002,887 shares
    Change vs previous 13F 0 shares

    1.15% of the 13F portfolio, value $45,672,941.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2025-03-31
    13F 4,002,887 shares
    Change vs previous 13F +190,672 shares

    0.71% of the 13F portfolio, value $29,541,306.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-12-31
    13F 3,812,215 shares
    Change vs previous 13F not available

    1.46% of the 13F portfolio, value $70,259,122.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).